AIDS (London, England) · 2026
Time-dependent mortality effects of dynamic antiretroviral therapy regimens.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Niu Yali, Li Ning, Shi Xuezhong, Jia Xiaocan, Zhao Chenyu, Wang Nana, Yang Yongli
Аннотация
INTRODUCTION: To compare the mortality effects of dynamic antiretroviral therapy (ART) regimens among people with HIV (PWH), while accounting for time-varying CD 4+ T cell counts and HIV viral loads.
METHODS: Leveraging data from 32 713 ART-naïve individuals (2015-2024) in Henan, China, we compared three approaches: baseline, time-fixed Cox model that classified participants by ART class at initiation, time-varying Cox model that updated ART class over follow-up; and marginal structural model (MSM) to address time-varying confounding. ART regimens were classified as nonnucleoside reverse transcriptase inhibitor (NNRTI)-, integrase strand transfer inhibitor (INSTI)-, or protease inhibitor (PI)-based regimens (reference: NNRTI). Outcomes included all-cause mortality and AIDS-related mortality.
RESULTS: Effect estimates shifted from the baseline time-fixed model toward stronger protective associations after incorporating time-updated ART exposure and further adjusting for time-varying confounding. In the MSM, compared with NNRTI-based regimens, INSTI- and PI-based regimens were associated with lower all-cause mortality [INSTI: hazard ratio (HR) = 0.38, 95% confidence interval (CI): 0.29-0.49; PI: HR=0.69, 95% CI: 0.52-0.91] and lower AIDS-related mortality (INSTI: HR = 0.31, 95% CI: 0.17-0.57; PI: HR = 0.47, 95% CI: 0.25-0.89). Secondary exploratory cumulative exposure analyses yielded patterns broadly consistent with lower mortality for INSTI exposure, whereas estimates for PI exposure were closer to the null and should be interpreted cautiously.
CONCLUSION: Accounting for time-updated ART exposure and time-varying confounding, INSTI-based regimens were associated with lower all-cause and AIDS-related mortality than NNRTI-based regimens. These findings underscore the need to account for dynamic ART exposure and time-varying confounding in observational comparative effectiveness studies of ART regimens.
METHODS: Leveraging data from 32 713 ART-naïve individuals (2015-2024) in Henan, China, we compared three approaches: baseline, time-fixed Cox model that classified participants by ART class at initiation, time-varying Cox model that updated ART class over follow-up; and marginal structural model (MSM) to address time-varying confounding. ART regimens were classified as nonnucleoside reverse transcriptase inhibitor (NNRTI)-, integrase strand transfer inhibitor (INSTI)-, or protease inhibitor (PI)-based regimens (reference: NNRTI). Outcomes included all-cause mortality and AIDS-related mortality.
RESULTS: Effect estimates shifted from the baseline time-fixed model toward stronger protective associations after incorporating time-updated ART exposure and further adjusting for time-varying confounding. In the MSM, compared with NNRTI-based regimens, INSTI- and PI-based regimens were associated with lower all-cause mortality [INSTI: hazard ratio (HR) = 0.38, 95% confidence interval (CI): 0.29-0.49; PI: HR=0.69, 95% CI: 0.52-0.91] and lower AIDS-related mortality (INSTI: HR = 0.31, 95% CI: 0.17-0.57; PI: HR = 0.47, 95% CI: 0.25-0.89). Secondary exploratory cumulative exposure analyses yielded patterns broadly consistent with lower mortality for INSTI exposure, whereas estimates for PI exposure were closer to the null and should be interpreted cautiously.
CONCLUSION: Accounting for time-updated ART exposure and time-varying confounding, INSTI-based regimens were associated with lower all-cause and AIDS-related mortality than NNRTI-based regimens. These findings underscore the need to account for dynamic ART exposure and time-varying confounding in observational comparative effectiveness studies of ART regimens.